Lobbying client
GRACEWAY PHARMACEUTICALS
Pharmaceutical manufacturing
Filings
15
Filed by
1
Reported in-house
—
Reported by firms
$150,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2008 to 2011
Filings
1 filing for 2011, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination (No Activity) 1st Quarter 2011
|
HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | 12 | $150,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 8 |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.